Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE: Patient Preference for Everolimus vs Capecitabine/Bevacizumab in Advanced Breast Cancer
NCT02248571Phase 4Completed
- Sponsor
- iOMEDICO
- Start
- Aug 2014
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in breast cancer, sponsored by iOMEDICO. Started Aug 2014; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02248571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02248571.